Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spermidine mediates acetylhypusination of RIPK1 to suppress diabetes onset and progression. | Nat Cell Biol | 2024 | 39511379 | PubTator, text mining | PubMed |
| Variants in the N-acetyltranferase 2 gene, acetylator phenotypes and their association with tuberculosis: Findings in Peruvian patients. | J Clin Tuberc Other Mycobact Dis | 2024 | 39502413 | PubTator, text mining | PubMed |
| [Guidelines for diagnosis and management of drug-induced liver injury caused by anti-tuberculosis drugs (2024 version)]. | Zhonghua Jie He He Hu Xi Za Zhi | 2024 | 39497389 | PubTator, text mining | PubMed |
| Accounting for genetic effect heterogeneity in fine-mapping and improving power to detect gene-environment interactions with SharePro. | Nat Commun | 2024 | 39478020 | PubTator, text mining | PubMed |
| N-Acetyltransferase 2 gene polymorphism and its serum levels in vitiligo patients. | J Immunoassay Immunochem | 2024 | 39404470 | PubTator, text mining | PubMed |
| Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. | Front Pharmacol | 2024 | 39364056 | PubTator, text mining | PubMed |
| An Investigational Study on the Role of CYP2D6, CYP3A4 and UGTs Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers. | Pharmaceuticals (Basel) | 2024 | 39338398 | PubTator, text mining | PubMed |
| Differential distribution of NAT2 polymorphisms and NAT2 acetylator phenotypes among indigenous populations of the Brazilian Amazon. | Pharmacogenet Genomics | 2024 | 39259702 | PubTator, text mining | PubMed |
| Editorial: Utilization of pharmacogenomics in clinical practice. | Front Genet | 2024 | 39228415 | PubTator, text mining | PubMed |
| Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis. | Expert Opin Drug Saf | 2024 | 39212296 | PubTator, text mining | PubMed |
| Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis. | Eur J Drug Metab Pharmacokinet | 2024 | 39153028 | PubTator, text mining | PubMed |
| Telomere-related gene risk model for prognosis prediction in colorectal cancer. | Transl Cancer Res | 2024 | 39145075 | PubTator, text mining | PubMed |
| Conceptual frameworks for the integration of genetic and social epidemiology in complex diseases. | Glob Epidemiol | 2024 | 39104369 | PubTator, text mining | PubMed |
| Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection. | BMC Infect Dis | 2024 | 39085767 | PubTator, text mining | PubMed |
| Determination of NAT2 Genotypes in a Cohort of Patients with Suspected TB in the State of Rio de Janeiro. | Pharmaceutics | 2024 | 39065614 | PubTator, text mining | PubMed |
| Methodological and Statistical Considerations for Cross-Sectional, Case-Control, and Cohort Studies. | J Clin Med | 2024 | 39064045 | PubTator, text mining | PubMed |
| Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis. | Clin Pharmacokinet | 2024 | 38990504 | PubTator, text mining | PubMed |
| Value analysis of ITLN1 in the diagnostic and prognostic assessment of colorectal cancer. | Transl Cancer Res | 2024 | 38988920 | PubTator, text mining | PubMed |
| N-acetyltransferase Gene Variants Involved in Pediatric Idiosyncratic Drug-Induced Liver Injury. | Biomedicines | 2024 | 38927494 | PubTator, text mining | PubMed |
| Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis. | Int J Mycobacteriol | 2024 | 38916393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=7